Activation of the protective Survivor Activating Factor Enhancement (SAFE) pathway against reperfusion injury: Does it go beyond the RISK pathway? (Q34974091)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	Activation of the protective Survivor Activating Factor Enhancement (SAFE) pathway against reperfusion injury: Does it go beyond the RISK pathway?	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

5 August 2017

1 reference

Europe PubMed Central

Activation of the protective Survivor Activating Factor Enhancement (SAFE) pathway against reperfusion injury: Does it go beyond the RISK pathway? (English)

1 reference

Europe PubMed Central

5 August 2017

reperfusion injury

1 reference

based on heuristic

inferred from title

author name string

Sandrine Lecour

1

1 reference

Europe PubMed Central

5 August 2017

publication date

31 March 2009

1 reference

Europe PubMed Central

5 August 2017

Journal of Molecular and Cellular Cardiology

1 reference

Europe PubMed Central

5 August 2017

47

1 reference

Europe PubMed Central

5 August 2017

32-40

1 reference

Europe PubMed Central

5 August 2017

1

1 reference

Europe PubMed Central

5 August 2017

Reperfusion injury and its pharmacologic modification

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2009.03.019

7 January 2021

Myocardial reperfusion injury.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2009.03.019

7 January 2021

Preconditioning with ischemia: a delay of lethal cell injury in ischemic myocardium

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2009.03.019

7 January 2021

Inhibition of myocardial injury by ischemic postconditioning during reperfusion: comparison with ischemic preconditioning

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2009.03.019

7 January 2021

Long-term benefit of postconditioning

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2009.03.019

7 January 2021

Fighting the "fire" of myocardial reperfusion injury: how to define success?

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2009.03.019

7 January 2021

Reperfusion injury in humans: a review of clinical trials on reperfusion injury inhibitory strategies

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2009.03.019

7 January 2021

Multiple protective pathways against reperfusion injury: a SAFE path without Aktion?

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2009.03.019

7 January 2021

Effect of cyclosporine on reperfusion injury in acute myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2009.03.019

7 January 2021

The mitochondrial permeability transition pore: its fundamental role in mediating cell death during ischaemia and reperfusion

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2009.03.019

7 January 2021

New directions for protecting the heart against ischaemia-reperfusion injury: targeting the Reperfusion Injury Salvage Kinase (RISK)-pathway

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2009.03.019

7 January 2021

Stress-activated cytokines and the heart: from adaptation to maladaptation

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2009.03.019

7 January 2021

TNFalpha is required to confer protection in an in vivo model of classical ischaemic preconditioning

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2009.03.019

7 January 2021

Bidirectional role of tumor necrosis factor-alpha in coronary microembolization: progressive contractile dysfunction versus delayed protection against infarction.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2009.03.019

7 January 2021

Innate immunity and cardiac preconditioning: a putative intrinsic cardioprotective program

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2009.03.019

7 January 2021

Innate immunity and myocardial adaptation to ischemia

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2009.03.019

7 January 2021

Pharmacological preconditioning with tumor necrosis factor-alpha activates signal transducer and activator of transcription-3 at reperfusion without involving classic prosurvival kinases (Akt and extracellular signal-regulated kinase).

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2009.03.019

7 January 2021

Dual activation of STAT-3 and Akt is required during the trigger phase of ischaemic preconditioning

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2009.03.019

7 January 2021

Cardioprotection: nitric oxide, protein kinases, and mitochondria

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2009.03.019

7 January 2021

Ligand triggers of classical preconditioning and postconditioning

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2009.03.019

7 January 2021

Ischemic postconditioning in pigs: no causal role for RISK activation.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2009.03.019

7 January 2021

Sphingosine can pre- and post-condition heart and utilizes a different mechanism from sphingosine 1-phosphate

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2009.03.019

7 January 2021

Identification of a novel role for sphingolipid signaling in TNF alpha and ischemic preconditioning mediated cardioprotection

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2009.03.019

7 January 2021

Classic ischemic but not pharmacologic preconditioning is abrogated following genetic ablation of the TNFalpha gene

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2009.03.019

7 January 2021

Cardioprotection by ischemic postconditioning is lost in aged and STAT3-deficient mice

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2009.03.019

7 January 2021

Coronary microembolization: the role of TNF-alpha in contractile dysfunction

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2009.03.019

7 January 2021

Elevated circulating levels of tumor necrosis factor in severe chronic heart failure

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2009.03.019

7 January 2021

TNF alpha receptor expression in rat cardiac myocytes: TNF alpha inhibition of L-type Ca2+ current and Ca2+ transients

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2009.03.019

7 January 2021

Expression and functional significance of tumor necrosis factor receptors in human myocardium

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2009.03.019

7 January 2021

Tumour necrosis factor-alpha uncouples respiration in isolated rat mitochondria.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2009.03.019

7 January 2021

Inflammatory mediators and the failing heart: past, present, and the foreseeable future

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2009.03.019

7 January 2021

Delayed expression of cytokines after reperfused myocardial infarction: possible trigger for cardiac dysfunction and ventricular remodeling

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2009.03.019

7 January 2021

Improved myocardial ischemia/reperfusion injury in mice lacking tumor necrosis factor-alpha

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2009.03.019

7 January 2021

TNF-alpha antibodies are as effective as ischemic preconditioning in reducing infarct size in rabbits

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2009.03.019

7 January 2021

Anti-tumor necrosis factor-alpha improves myocardial recovery after ischemia and reperfusion

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2009.03.019

7 January 2021

Endogenous tumor necrosis factor protects the adult cardiac myocyte against ischemic-induced apoptosis in a murine model of acute myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2009.03.019

7 January 2021

Tumor necrosis factor-alpha confers resistance to hypoxic injury in the adult mammalian cardiac myocyte.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2009.03.019

7 January 2021

The role of TNF-alpha receptors p55 and p75 in acute myocardial ischemia/reperfusion injury and late preconditioning

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2009.03.019

7 January 2021

Tumor necrosis factor-alpha is toxic via receptor 1 and protective via receptor 2 in a murine model of myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2009.03.019

7 January 2021

TNFalpha in myocardial ischemia/reperfusion: damage vs. protection

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2009.03.019

7 January 2021

Tumor necrosis factor-alpha and its receptors 1 and 2: Yin and Yang in myocardial infarction?

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2009.03.019

7 January 2021

Plasma cytokine parameters and mortality in patients with chronic heart failure

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2009.03.019

7 January 2021

Cytokines and cytokine receptors in advanced heart failure: an analysis of the cytokine database from the Vesnarinone trial (VEST).

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2009.03.019

7 January 2021

Free radicals trigger TNF alpha-induced cardioprotection

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2009.03.019

7 January 2021

TNFalpha-induced cytoprotection requires the production of free radicals within mitochondria in C2C12 myotubes

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2009.03.019

7 January 2021

Tumor necrosis factor-induced protection of the murine heart is independent of p38-MAPK activation.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2009.03.019

7 January 2021

The role of ADAM protease in the tyrosine kinase-mediated trigger mechanism of ischemic preconditioning

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2009.03.019

7 January 2021

Role of tumor necrosis factor alpha and its receptor I in preconditioning by hyperoxia

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2009.03.019

7 January 2021

The involvement of cytokines in the second window of ischaemic preconditioning

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2009.03.019

7 January 2021

The mitochondrial permeability transition pore and the Ca2+-activated K+ channel contribute to the cardioprotection conferred by tumor necrosis factor-alpha

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2009.03.019

7 January 2021

Preconditioning the Myocardium: From Cellular Physiology to Clinical Cardiology

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2009.03.019

7 January 2021

The myocardial JAK/STAT pathway: from protection to failure

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2009.03.019

7 January 2021

The Jak-STAT pathway

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2009.03.019

7 January 2021

Activation of gp130 transduces hypertrophic signals via STAT3 in cardiac myocytes

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2009.03.019

7 January 2021

Signal transducer and activator of transcription 3 in the heart transduces not only a hypertrophic signal but a protective signal against doxorubicin-induced cardiomyopathy

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2009.03.019

7 January 2021

The type I angiotensin II receptor couples to Stat1 and Stat3 activation through Jak2 kinase in neonatal rat cardiac myocytes

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2009.03.019

7 January 2021

Activation of signal transducer and activator of transcription 3 protects cardiomyocytes from hypoxia/reoxygenation-induced oxidative stress through the upregulation of manganese superoxide dismutase

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2009.03.019

7 January 2021

An essential role of the JAK-STAT pathway in ischemic preconditioning

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2009.03.019

7 January 2021

Role of STAT3 in ischemic preconditioning

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2009.03.019

7 January 2021

Genetic depletion of cardiac myocyte STAT-3 abolishes classical preconditioning

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2009.03.019

7 January 2021

Cardiotrophin-1 can protect cardiac myocytes from injury when added both prior to simulated ischaemia and at reoxygenation.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2009.03.019

7 January 2021

Erythropoietin protects the infant heart against ischemia-reperfusion injury by triggering multiple signaling pathways

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2009.03.019

7 January 2021

Erythropoietin affords additional cardioprotection to preconditioned hearts by enhanced phosphorylation of glycogen synthase kinase-3 beta

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2009.03.019

7 January 2021

CB(2) cannabinoid receptor activation is cardioprotective in a mouse model of ischemia/reperfusion

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2009.03.019

7 January 2021

The JAK/STAT pathway is essential for opioid-induced cardioprotection: JAK2 as a mediator of STAT3, Akt, and GSK-3 beta

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2009.03.019

7 January 2021

Diabetes abolishes morphine-induced cardioprotection via multiple pathways upstream of glycogen synthase kinase-3beta

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2009.03.019

7 January 2021

Signal transducer and activator of transcription 3 is involved in the cardioprotective signalling pathway activated by insulin therapy at reperfusion

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2009.03.019

7 January 2021

STAT-3 overexpression and p21 up-regulation accompany impaired regeneration of fatty livers

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2009.03.019

7 January 2021

Regulation of Mcl-1 expression in rheumatoid arthritis synovial macrophages.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2009.03.019

7 January 2021

Atiprimod blocks STAT3 phosphorylation and induces apoptosis in multiple myeloma cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2009.03.019

7 January 2021

Cardiotrophin-1 is an essential factor in the natural defense of the liver against apoptosis

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2009.03.019

7 January 2021

Connexin 43 in ischemic pre- and postconditioning.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2009.03.019

7 January 2021

The complex of ciliary neurotrophic factor-ciliary neurotrophic factor receptor alpha up-regulates connexin43 and intercellular coupling in astrocytes via the Janus tyrosine kinase/signal transducer and activator of transcription pathway

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2009.03.019

7 January 2021

Ischemic preconditioning activates phosphatidylinositol-3-kinase upstream of protein kinase C

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2009.03.019

7 January 2021

Localizing extracellular signal-regulated kinase (ERK) in pharmacological preconditioning's trigger pathway

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2009.03.019

7 January 2021

PI3 kinase and not p42/p44 appears to be implicated in the protection conferred by ischemic preconditioning

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2009.03.019

7 January 2021

Inconsistent relation of MAPK activation to infarct size reduction by ischemic preconditioning in pigs

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2009.03.019

7 January 2021

Cross-talk between the survival kinases during early reperfusion: its contribution to ischemic preconditioning

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2009.03.019

7 January 2021

Ischemic preconditioning protects by activating prosurvival kinases at reperfusion

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2009.03.019

7 January 2021

Myocardial protection by insulin at reperfusion requires early administration and is mediated via Akt and p70s6 kinase cell-survival signaling

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2009.03.019

7 January 2021

Bradykinin limits infarction when administered as an adjunct to reperfusion in mouse heart: the role of PI3K, Akt and eNOS.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2009.03.019

7 January 2021

The reperfusion injury salvage kinase pathway: a common target for both ischemic preconditioning and postconditioning.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2009.03.019

7 January 2021

Inhibiting mitochondrial permeability transition pore opening: a new paradigm for myocardial preconditioning?

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2009.03.019

7 January 2021

STAT3 as an adapter to couple phosphatidylinositol 3-kinase to the IFNAR1 chain of the type I interferon receptor

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2009.03.019

7 January 2021

Carbon monoxide differentially modulates STAT1 and STAT3 and inhibits apoptosis via a phosphatidylinositol 3-kinase/Akt and p38 kinase-dependent STAT3 pathway during anoxia-reoxygenation injury.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2009.03.019

7 January 2021

TEL-JAK2 mediates constitutive activation of the phosphatidylinositol 3'-kinase/protein kinase B signaling pathway

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2009.03.019

7 January 2021

Mitogenic and antiapoptotic actions of hepatocyte growth factor through ERK, STAT3, and AKT in endothelial cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2009.03.019

7 January 2021

The PGE2-Stat3 interaction in doxorubicin-induced myocardial apoptosis

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2009.03.019

7 January 2021

Prostaglandin E2 activates Stat3 in neonatal rat ventricular cardiomyocytes: A role in cardiac hypertrophy

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2009.03.019

7 January 2021

Extracellular signal-regulated protein kinase (ERK)-dependent and ERK-independent pathways target STAT3 on serine-727 in human neutrophils stimulated by chemotactic factors and cytokines

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2009.03.019

7 January 2021

Distinctive role of Stat3 and Erk-1/2 activation in mediating interferon-gamma inhibition of TGF-beta1 action

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2009.03.019

7 January 2021

Production of growth related oncogene protein-alpha in human umbilical vein endothelial cells stimulated with soluble interleukin-6 receptor-alpha: role of signal transducers, janus kinase 2 and mitogen-activated kinase kinase

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2009.03.019

7 January 2021

STAT3 attenuates EGFR-mediated ERK activation and cell survival during oxidant stress in mouse proximal tubular cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2009.03.019

7 January 2021

Signaling pathways in ischemic preconditioning

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2009.03.019

7 January 2021

Sphingosine kinase activation mediates ischemic preconditioning in murine heart

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2009.03.019

7 January 2021

Cyclic GMP and protein kinase-G in myocardial ischaemia-reperfusion: opportunities and obstacles for survival signaling

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2009.03.019

7 January 2021

TNF-alpha, rheumatoid arthritis, and heart failure: a rheumatological dilemma

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2009.03.019

7 January 2021

Drug insight: anti-tumor-necrosis-factor therapy for ankylosing spondylitis

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2009.03.019

7 January 2021

Protection from obesity-induced insulin resistance in mice lacking TNF-alpha function

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2009.03.019

7 January 2021

Native and reconstituted HDL activate Stat3 in ventricular cardiomyocytes via ERK1/2: role of sphingosine-1-phosphate

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2009.03.019

7 January 2021

Peripartum cardiomyopathy: recent insights in its pathophysiology

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2009.03.019

7 January 2021

A cathepsin D-cleaved 16 kDa form of prolactin mediates postpartum cardiomyopathy.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2009.03.019

7 January 2021

Serum tumour necrosis factor-alpha, interleukin-2 and interleukin-10 activation in stable angina and acute coronary syndromes

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2009.03.019

7 January 2021

Tumor necrosis factor-alpha receptor 1 is a major predictor of mortality and new-onset heart failure in patients with acute myocardial infarction: the Cytokine-Activation and Long-Term Prognosis in Myocardial Infarction (C-ALPHA) study

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2009.03.019

7 January 2021

Tumor necrosis factor-alpha and mortality in heart failure: a community study

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2009.03.019

7 January 2021

Time course and prognostic significance of hemostatic changes in sepsis: relation to tumor necrosis factor-alpha

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2009.03.019

7 January 2021

Tumor necrosis factor-alpha is released from the isolated heart undergoing ischemia and reperfusion.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2009.03.019

7 January 2021

Identifiers

10.1016/J.YJMCC.2009.03.019

1 reference

Europe PubMed Central

5 August 2017

1 reference

Europe PubMed Central

5 August 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q34974091&oldid=1370944606"